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Follow-up of peritoneal clearances in patients undergoing con-
tinuous ambulatory peritoneal dialysis. Continuous ambulatory
peritoneal dialysis (CAPD) might result in peritoneal membrane
changes. First, CAPD exposes essentially continuously the pen-
toneum to peritoneal dialysis solutions. Such solutions differ
from the usual extracellular fluid bathing peritoneal tissues. Sec-
ond. this technique may be complicated by an increased frequen-
cy of peritonitis when compared to intermittent peritoneal dial-
ysis. We undertook a prospective study of patients undergoing
CAPD to determine if there were decreases in peritoneal clear-
ances and if the peritoneal microcirculation maintained its re-
sponsiveness to nitroprusside. Peritoneal transport, as assessed
by the clearances of urea, creatinine, inulin, and dialysate pro-
tein concentration, with and without nitroprusside addition to
the dialysis solution, is unchanged in patients undergoing CAPD
for up to 1 year, despite frequent episodes of peritonitis.
Surveillance de l'évolution des clearances péritonéales chez les
malades en dialyse péritonéale continue ambulatoire. La dialyse
péritonéale continue ambulatoire (CAPD) peut avoir pour con-
sequence des modifications du péritoine. En premier lieu, CAPD
expose Ic péritoine, de facon continue, aux solutions de dial-
yse. Ces solutions different du liquide extracellulaire normal qui
baigne cette séreuse. En second lieu cette technique a pour com-
plication des pdritonites dont Ia frequence est plus grande qu'au
cours de la dialyse péritonéale intermittente. Nous avons en-
trepris une étude prospective chez des malades soumis a CAPD
afin de savoir s'il apparait une diminution des clearances périto-
néales et Si Ia microcirculation péritonéale conserve sa capacité
de répondre au nitroprusside. Le transport péritonéal, évalué
par les clearances de l'urée, de La créatinine, de l'inuline et par la
concentration de protéines dans le dialysat, avec et sans nitro-
prusside dans Ia solution de dialyse, n'est pas modiflé chez les
malades soumis a CAPD pendant des durées allant jusqu'à un
an, malgré des episodes de péritonite frequents.
Continuous ambulatory peritoneal dialysis
(CAPD) has been shown to be effective as a dialysis
technique [1]. Peritoneal dialysis solution is present
in the peritoneal cavity 24 hours a day, 7 days a
week except for brief periods of drainage and in-
stillation of fresh solution four or five times per day.
A significant complication of this method of dialysis
is the increase in peritoneal infections when com-
pared to automated home peritoneal dialysis [1, 2].
Recurrent episodes of peritonitis with resulting fi-
brosis or adhesions might decrease effective perito-
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neal surface area and dialysis efficiency. In this re-
gard, some have reported that patients maintained
with intermittent peritoneal dialysis undergo a de-
crease in their effective peritoneal clearances of
urea and creatinine [3]. In addition, continuous
peritoneal contact with commercial dialysis solu-
tion (which contains high concentrations of lactate
or acetate) are relatively hypertonic and have pH val-
ues below 6, which might cause unknown long-term
alterations in peritoneal transport characteristics.
To investigate these possibilities, we undertook a
prospective study of patients undergoing CAPD to
determine if there were decreases in peritoneal
clearances over time and if the peritoneum main-
tained its responsiveness to nitroprusside. We have
shown previously that nitroprusside, a vasodilator,
enhances the clearance of urea (Cur), creatinine
(Ccr), inulin (C10), and the dialysate protein concen-
tration per dialysis exchange (DPC) [4]. This in-
crease in peritoneal clearance is likely due to an in-
crease in the number of capillaries perfused and in
capillary permeability (mean pore size) [4, 5].Ifcontinuous exposure of the peritoneum to dial-
ysis solutions and recurrent peritonitis significantly
alter baseline peritoneal clearances or the vascular
responsiveness of the peritoneal microcirculation
over 6 to 12 months, this would have important im-
plications relative to long-term CAPD.
Methods
Patient characteristics. Twelve patients volun-
teered to undergo CAPD as their mode of therapy
for end-stage renal disease. Patient age, sex, diag-
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nosis, and number of episodes of peritonitis are list-
ed in Table 1. Informed consent was obtained from
all patients. All patients were admitted to the Clini-
cal Research Center of the University of Missouri
for clearance studies during hourly exchanges at the
start of CAPD training and at least every 6 months
thereafter. Six of twelve patients have been studied
over 1 year; the others, over 6 months. Hourly ex-
changes were chosen for clearance measurements
rather than long-dwell exchanges. With the latter,
clearances, particularly for small solutes, are de-
pendent on dialysate flow rate rather than on mem-
brane properties.
Clearance studies. Peritoneal access was via a
Tenckhoff catheter [6]. The dialysis solution used
was Dianeal® (Baxter-Travenol Laboratories,
Deerfield, Illinois), Dialysate used for hourly ex-
changes contained 1.5% glucose, and, per liter, 141
mEq of sodium, 101 mEq of chloride, 3.5 mEq of
calcium, 1.5 mEq of magnesium, and 45 mEq of lac-
tate. It had a pH of 5.1 and an osmolality of 347
mOsm/kg. Peritoneal C1, Cur, Ccr, and DPC were
studied without (control) and with nitroprusside
added to the dialysis solution. Nitroprusside was
not added to the dialysis solution in two patients
with advanced coronary artery disease in whom
even mild decreases in blood pressure (usually less
than 10 mm Hg, diastolic) were deemed undesirable
and in three patients who agreed to control but not
vasodilator-containing exchanges.
Following drainage of the previous long-dwell ex-
change and three in and out 1-liter wash-out ex-
changes, a study was started. A dialysis study con-
sisted of three 2-liter control exchanges followed by
three 2-liter exchanges containing 4.5 mg of nitro-
prusside (Nipride®) per liter. Potassium chloride, 4
Table 1. Patient characteristics
Episodes
of peritonitis
Patient
no.
Age
yr Sex Diagnosis
0 to 6 6 to 12
months months
1
2
3
4
5
6
7
8
9
10
11
12
38
51
45
77
69
42
60
61
60
57
49
68
F
F
F
M
M
F
M
M
M
M
F
F
Focal glomerulosclerosis
Chronic interstitial nephritis
Membranous nephritis
Obstructive uropathy
Chronic interstitial nephritis
Nephrosclerosis
Chronic glomerulonephritis
Chronic glomerulonephritis
Chronic interstitial nephritis
Chronic glomerulonephritis
Diabetes mellitus
Chronic interstitial nephritis
1 4
5 6
3 1
3
0
5 6
2 4
0 2
10
3
2
2
to 6 mEq/liter, and heparin, 500 U per 2 liters, were
added to all exchanges. Study exchanges were per-
formed by instilling the 2 liters of dialysis solution
via gravity over 10 mm, allowing intraperitoneal
dwell for 30 mm and drainage for 20 mm. The drain-
age volume was measured in a graduated cylinder.
Technical. Concentrations of serum urea, creati-
nine, and dialysate urea and creatinine were deter-
mined by the Technicon autoanalyzer II. Inulin
concentrations in serum and dialysate were deter-
mined by a modification of the method of Walser,
Davidson, and Orloff[7]. The concentration of pro-
tein in dialysate drainage was determined by tn-
chioroacetic acid precipitation [8].
Calculations. Peritoneal clearances were calcu-
lated as follows: peritoneal drainage volume (VD), in
milliliters, divided by the duration of dialysis ex-
change from the beginning of inflow to completion
of drainage (t), multiplied by the dialysate concen-
tration of the solute to be studied (D) divided by the
serum concentration (P). That is:
[D]VDC,rnllmzn
Serum concentrations changed very little through-
out any study. Blood was sampled for clearance cal-
culations at the beginning and end of each study and
then interpolated to the beginning of each ex-
change.
Statistics. The mean clearance value, drainage
volume, and DPC were determined for exchanges
with and without nitroprusside. All data per study
were reported as one mean value per patient for
control and nitroprusside exchanges, respectively.
Paired data were analyzed statistically. The
paired t test (two tailed) was used to see if dif-
ferences in clearances at initiation and following 6
or 12 months of CAPD were significant. The null
hypothesis was rejected at P less than 0.05. At each
time period, differences in paired values without
and with nitroprusside were analyzed similarly. For
each study, the time since onset of the last previous
episode of peritonitis was noted. Mean clearance
values for weekly intervals following peritonitis
were calculated from all data and compared by non-
paired t analysis.
Results
Mean clearances and DPC are detailed in Table 2.
Control peritoneal creatinine clearances increased
slightly but significantly at 1 year, but not at 6
months. Control peritoneal inulin clearances in-
creased significantly at 6 months, but not at 1 year.
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Table 2. Clearances and dialysate protein concentration with time of patients on CAPDa
Start 6 months 12 months
Control Ni Control Ni Control Ni
Urea,mllmin
Creatinine,ml/min
Inulin,mllmin
Dialysate protein
concentration, mg/dl
Drainage volume, ml
18.3 0.5
(N = 12)
12.2 0.9
(N = 12)
3.3 0.3
(N = 12)
35.1 6.0
(N = 11)
2162 31
(N = 12)
22.6 2.0
(N = 7)
16.1 2.0
(N = 7)
4.6 0.7
(N = 7)
74.0 20.0
(N = 5)
2256 62
(N = 7)
18.6 0.9
(N = 12)
13.2 1.0
(N = 12)
4.7 O.Sb
(N = 12)
35.3 4.7
(N 12)
2131 59
(N = 12)
21.6 1.2
(N = 11)
15.0 1.45
(N = II)
5.2 0.7
(N = 11)
58.4 7.2
(N = 11)
2272 53
(N = 7)
18.1 0.4
(N = 6)
13.4 0.6c
(N = 6)
3.9 0.6
(N = 6)
36.7 8.7(N 6)
2178 21
(N = 6)
19.8 1.1
(N = 6)
14.9 0.7
(N = 6)
4.5 0.7
(N = 6)
62.0 10.3
(N = 6)
2154 53
(N = 6)
Values are means SEM. Ni signifies "with nitroprusside," 4.5 mg/liter. N is number of patients studied.
bp < 0.025, 6 months' control to start control by paired analysis.
P < 0.05, 12 months' control to start control by paired analysis.
Values with nitroprusside showed no significant dif- clearances of urea at the start of peritoneal dialysis
ferences at 6 and 12 months as compared to starting and after 6 months. The clearances of creatinine
nitroprusside values. There were no significant dif- and inulin as well as DPC were significantly in-
ferences in volumes over time or with and without creased at the beginning of CAPD, but not after 6
nitroprusside. months. Although nitroprusside did not always re-
Figure 1 shows mean control values at 0, 6, and sult in significant differences, especially with small-
12 months on CAPD in the six patients studied for I er numbers at 12 months, no trends for changes in
year. No sustained trends are apparent. Four of the magnitude of clearances or DPC with or without
these patients underwent paired control and nitro- nitroprusside are seen.
prusside studies each time. Table 3 shows mean values from all studies oc-
Mean values for paired nitroprusside and control curring with 1, 2, 3, 4, or 4 or more weeks of perito-
exchanges are shown in Figs. 2 to 5 for seven pa- nitis. Patients with signs and symptoms of active
tients at 0 and 6 months, and for four patients at 12 peritonitis were not studied. All had clear drainage.
months. The addition of nitroprusside to the dial- As seen in Table 3, most studies were more than 4
ysis solution significantly increased the peritoneal weeks away from clinical peritonitis. Those few
studies within I to 4 weeks of clinical peritonitis of-
3O 30
25
20 20
15 15
° 10
5 5
fer the opportunity to look for postperitonitis
changes. No significant differences are seen be-
tween any values at different times after peritonitis.
Protein concentrations in these hourly drainages are
lower than they are in long-dwell CAPD exchanges
[1].
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Fig. 1. Mean control clearances and dialysate protein concen-
trations after 0, 6, and 12 months on CAPD in six patients fol-
Fig. 2.
and
Mean (±5EM)peritoneal
nitroprusside
urea clearances
(Nipride®)containing exchanges
(Cur) for control
at 0, 6, and
lowed 1 year. 12 months on CAPD. N is number of patients.
N
Control Nipride
0 mos on CAPD
N
?0.025
Control Nipride
6 mos on CAPD
Control Nipride
12 moson CAPD
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14,
Control Nipride Control Nipride
6 mos on CAPD 12 mos on CAPD
clearances in the same format as that
Dialysate protein concentrations and peritoneal
clearances of urea, creatinine, and inulin without
and with augmentation by nitroprusside remained
similar over 6 months of CAPD. Six patients fol-
lowed for 1 year showed similar stability of values.
Eleven of twelve patients had at least one episode
of peritonitis. Even in two patients who had eleven
episodes, peritoneal clearances did not decrease.
Early diagnosis and treatment may have prevented
permanent major alterations in the peritoneum. We
did not observe clearance changes or increased pro-
tein concentrations even within a week of resolu-
tion of clinical peritonitis. Although increased pro-
tein losses may occur during peritonitis, our studies
suggest that prompt therapy, usually clearing clini-
cal signs and symptoms within 24 to 48 hours, also
restores baseline peritoneal transport properties—
at least in these patients on CAPD. For 2 to 3 weeks
following peritonitis, patients were usually on an in-
traperitoneal antibiotic (most commonly cephalo-
thin, 125 mg/liter). This also did not apparently af-
fect peritoneal transport characteristics.
Blumenkrantz has reported increased protein
concentration for 6 to 8 weeks after peritonitis in
patients on intermittent peritoneal dialysis [9]. Re-
turns to baseline within 1 week in our patients may
relate to very early diagnosis and treatment possible
in CAPD patients and/or effects of continuous dial-
ysis.
Peritoneal clearances with nitroprusside were
usually higher than with regular solutions. The pres-
ervation of responsiveness to nitroprusside sug-
gests that the peritoneal microcirculation is not al-
tered in any major way. This is of interest because
recent work has shown that commercial dialysis so-
lutions cause transient (3 to 5 mm) vasoconstriction
Table 3. Clearances related to weeks postperitonitisa
Time since
onset of last
peritonitis
Control exchanges Nitroprusside exchanges
Cur Ccr C, Protein Cur Ccr C1 Protein
wks mi/mm mi/mm rnl/rnin mg/dl mi/rn in mi/mm mi/mm mg/di
1 19.9 1.0
(N = 4)
15.2 1.8
(N = 4)
5.1 1.2
(N = 4)
27 6.6
(N = 4)
21.4 1.0
(N 3)
17.2 3.7
(N 3)
6.4 2.2
(N = 3)
54 8.0
(N = 3)
2 17.4 0.9
(N= 5)
12.1 0.7
(N = 5)
3.1 0.4
(N = 5)
26 5.5
(N = 5)
19.4 1.4
(N = 5)
14.1 1.5
(N = 5)
4.5 0.7
(N = 5)
59 9.2
(N = 5)
3 18.1 2.0
(N= 3)
10.6 2.3
(N = 3)
3.2 0.5
(N= 3)
29 6.7
(N = 3)
19.6 1.1
(N = 3)
11.8 2.8
(N = 3)
3.4 0.4
(N = 3)
51 16
(N = 3)
4 16.9 1.0
(N = 4)
13.5 0.7
(N= 4)
4.4 0.8
(N= 4)
36 10
(N = 4)
17.7 1.6
(N = 4)
14.0 0.7
(N = 4)
4.7 1.0
(N = 4)
50 12
(N = 4)
>4 18.6 0.5
(N= 30)
12.1 0.6
(N = 30)
3.7 0.3
(N = 29)
35 4.1
(N = 27)
22.3 0.9
(N = 20)
14.6 1.2
(N = 20)
4.6 0.5
(N = 19)
64 8.9
(N = 17)
a Values are means SEM. N denotes number of studies represented.
12-
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Discussion
Control Nipride
0 mos on CAPD
FIg. 3. Mean creatinine
shown in Fig. 2.
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OmosonCAPO 6mosonCAPD l2mosonCAPD
Fig. 4. Mean inulin clearances in the same form at as that shown
in Fig. 2.
120
.E 100
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Control Nipride Control Nipride Control Nipride
0 mos on CAPD 6 mos on CAPD 12 mos on CAPO
Fig. 5. Mean dialysate protein concentrations in the same for-
mat as that shown in Fig. 2.
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followed by vasodilatation when applied topically
to the microcirculation of the rat cremaster [10]. Re-
peated exposure to vasoactive solutions appear not
to cause irreversible constriction or dilation.
As assessed by Cur, Ccr, C1, DPC, and changes
in these values after nitroprusside addition to the
dialysis solution, peritoneal transport character-
istics seem very stable in patients undergoing
CAPD for up to 12 months, even with frequent peri-
tonitis. Their stable serum concentrations of urea
nitrogen and creatinine over many months, as pre-
viously reported, support these findings [11]. This is
encouraging for at least two reasons. First, CAPD
in the above studies was conducted entirely with
bottled solutions. It has been shown that the risk of
infection is less with solution in plastic bags be-
cause the mechanics of drainage and instillation are
facilitated [12]. Thus, future CAPD presumably will
be associated with lower infection rates and even
less chance for the development of fibrosis and ad-
hesions. Second, the clearance of small solutes is
partly limited by dialysate flow and, therefore, long-
dwell clearances of urea and creatinine are well be-
low values achieved during the 1-hour exchanges
used in this study. Therefore, small solute clear-
ances during actual CAPD should approximate the
dialysate flow rate and would be relatively in-
sensitive to any changes detected during hourly ex-
changes [13]. In contrast, the clearances of very
large solutes are well below dialysate flow rates dur-
ing long-dwell exchanges and would be sensitive to
area and permeability changes even at slower dialy-
sate flow rates used during actual CAPD. Because
weekly large solute clearances during CAPD are
many times weekly clearances on 15 hours of hemo-
dialysis, however, major decreases in CAPD min-
ute clearances could occur before CAPD weekly
clearances decreased to standard hemodialysis
weekly clearances [14].
Thus, the absence of a significant decrease in
clearances over 12 months with very high rates of
infection suggests that CAPD, particularly with the
advent of low infection rates, may permit effective
dialysis over many years. This limited 12-month fol-
low-up of six patients on CAPD certainly does not
prove, however, that the technique can be used in-
definitely for most people. Additional studies in
more patients over even longer periods will be nec-
essary.
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